跳至主要内容
临床试验/NCT00452855
NCT00452855已完成不适用

Postoperative Nausea and Vomiting Are Similar When Propofol or Sevoflurane Are Used as Adjuvant to Remifentanil During Anaesthesia for Gynaecological Surgery

Central Jutland Regional Hospital2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2002年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160
试验地点
2
主要终点
Nausea, incidence and intensity ( VAS score )in PACU and surgical ward

研究概览

简要总结

The purpose of this study is to determine whether sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia concerning post- operative nausea and vomiting.

详细描述

Propofol and sevoflurane anaesthesia are used world wide at the anaesthetists discretion.

Propofol is superior to inhalational anaesthetics as anaesthesia for patients at risk of post operative nausea and vomiting (PONV) as PONV is diminished. However, when remifentanil is used as adjuvant to sevoflurane, the total dose of the latter is reduced.

Therefore, we wanted to investigate if sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia with emphasis on nausea, vomiting and total PONV during 24 hours.

In the post anaesthesia care unit (PACU) and in the surgical ward nausea was scored on a visual analogue score. Vomiting was registered.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Females younger than 50 years
  • Scheduled to gynaecological laparotomies or laparoscopies

排除标准

  • Medication known to act anti-emetic
  • ASA status greater than II
  • Malignant hyperthermia
  • Allergy to the drugs used.

结局指标

主要结局

Nausea, incidence and intensity ( VAS score )in PACU and surgical ward

Vomiting, incidence in PACU and surgical ward

Total PONV after 24 hours

次要结局

未报告次要终点

研究者

发起方
Central Jutland Regional Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验